These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 25015036)
1. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis. Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036 [TBL] [Abstract][Full Text] [Related]
2. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression. Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Sengupta S; Chatterjee J J Clin Pathol; 2010 Oct; 63(10):894-9. PubMed ID: 20876321 [TBL] [Abstract][Full Text] [Related]
3. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis. Das RK; Anura A; Pal M; Bag S; Majumdar S; Barui A; Chakraborty C; Ray AK; Sengupta S; Paul RR; Chatterjee J Exp Mol Pathol; 2013 Dec; 95(3):259-69. PubMed ID: 23994666 [TBL] [Abstract][Full Text] [Related]
4. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis. Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387 [TBL] [Abstract][Full Text] [Related]
5. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer. Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241 [TBL] [Abstract][Full Text] [Related]
6. Computer-aided molecular pathology interpretation in exploring prospective markers for oral submucous fibrosis progression. Anura A; Conjeti S; Das RK; Pal M; Paul RR; Bag S; Ray AK; Chatterjee J Head Neck; 2016 May; 38(5):653-69. PubMed ID: 25532458 [TBL] [Abstract][Full Text] [Related]
7. Collagen deposition correlates with loss of E-cadherin and increased p63 expression in dysplastic conditions of oral submucous fibrosis. Chakraborti S; Paul RR; Pal M; Chatterjee J; Das RK Med Mol Morphol; 2022 Mar; 55(1):20-26. PubMed ID: 34482436 [TBL] [Abstract][Full Text] [Related]
8. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study. Thubashini M; Malathi N; Kannan L Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896 [TBL] [Abstract][Full Text] [Related]
9. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis. Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582 [TBL] [Abstract][Full Text] [Related]
10. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis. Jayasooriya PR; Nadeeka Jayasinghe KA; Mudiyanselage Tilakaratne W J Investig Clin Dent; 2011 Aug; 2(3):171-5. PubMed ID: 25426787 [TBL] [Abstract][Full Text] [Related]
11. Epithelial Distribution of E-Cadherin, p63, and Mitotic Figures in ApoTome Images to Determine the Oncogenic Potentiality of Oral Submucous Fibrosis. Nag R; Paul RR; Pal M; Chatterjee J; Das RK Microsc Microanal; 2020 Dec; 26(6):1198-1210. PubMed ID: 33050978 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of prime molecules in cervical lesions towards assessment of malignant potentiality. Das L; Naskar S; Sarkar T; Maiti AK; Das S; Chatterjee J J Cancer Res Ther; 2018; 14(2):377-381. PubMed ID: 29516923 [TBL] [Abstract][Full Text] [Related]
13. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes. Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243 [TBL] [Abstract][Full Text] [Related]
14. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study. Pammar C; Nayak RS; Kotrashetti VS; Hosmani J J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335 [TBL] [Abstract][Full Text] [Related]
15. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
16. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast. Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158 [TBL] [Abstract][Full Text] [Related]
17. ApoTome to visualize E-cadherin and p63 expression in oral pre-cancer. Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Chatterjee J Biotechnol J; 2012 May; 7(5):602-7. PubMed ID: 21898830 [TBL] [Abstract][Full Text] [Related]
18. High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis. Chien CY; Su CY; Hwang CF; Chuang HC; Chen CM; Huang CC J Surg Oncol; 2006 Oct; 94(5):413-7. PubMed ID: 16967447 [TBL] [Abstract][Full Text] [Related]
19. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor. Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]